Ann Rheum Dis
- COHEN P, Ziff D, Lipsky PE
Morris Ziff.
Ann Rheum Dis. 2024;83:417-420.
- WINTHROP KL, Mease P, Kerschbaumer A, Voll RE, et al
Unmet need in rheumatology: reports from the Advances in Targeted Therapies
meeting, 2023.
Ann Rheum Dis. 2024;83:409-416.
- MELOKHINA V, Paulshus Sundlisaeter N, Sexton J, Sundin U, et al
Subclinical inflammation and joint damage progression in patients with early RA
fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the
ARCTIC study.
Ann Rheum Dis. 2024;83:540-541.
Arthritis Res Ther
- CHRIST L, Kissling S, Finckh A, Fisher BA, et al
Concomitant Sjogren's disease as a biomarker for treatment effectiveness in
rheumatoid arthritis - results from the Swiss clinical quality management cohort.
Arthritis Res Ther. 2024;26:68.
- CHANG L, Zheng Z, Zhou Y, Liu K, et al
B cell receptor repertoire analysis in primary Sjogren's syndrome salivary glands
identifies repertoire features associated with clinical activity.
Arthritis Res Ther. 2024;26:62.
Clin Exp Rheumatol
- LEBEL N, Marie I, Grosjean J, Brevet P, et al
Potential efficacy of T and B lymphocyte-targeted therapies on articular
involvement of patients with rheumatoid arthritis and systemic sclerosis overlap
syndrome. Results from a 2-centre series of 22 cases.
Clin Exp Rheumatol. 2024.
Clin Rheumatol
- HARADA H, Kondo M, Maeyama A, Fukuda T, et al
Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid
arthritis: A multicenter, retrospective, inverse probability of
treatment-weighted analysis based on the FRAB-registry.
Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
- ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
Persistence on subcutaneous tocilizumab as monotherapy or in combination with
synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients
in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional,
observational
Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
- OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
Evaluation of the prognostic nutritional index (PNI) as a tool for assessing
disease activity in rheumatoid arthritis patients.
Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
Immunology
- XUAN Y, Zhang X, Wu H
Impact of sex differences on the clinical presentation, pathogenesis, treatment
and prognosis of Sjogren's syndrome.
Immunology. 2024;171:513-524.
PLoS One
- SHRESTHA DS, Manandhar S, Chalise BS, Rajbhandari SK, et al
Symptoms 6 months following SARS-CoV-2 infection in Nepali women.
PLoS One. 2024;19:e0299141.
Rheumatol Int
- BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
Associations of gender with sexual functioning, loneliness, depression, fatigue
and physical function amongst patients suffering from rheumatoid arthritis with a
particular focus on methotrexate usage.
Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
- SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid
arthritis: result from COVAD e-survey study.
Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016